Free Neurology CME | CMEList.com

 


The Best of Stroke Forum 2016  Free Stroke CME
Posted by...Bernard Sklar, MD. 
Free CME Credit Hours...0.5.
CME Credits Awarded by...Vindico Medical Education.
Cost for Credit...Free.
Instruction Type...Video Lectures.
Target Audience...Emergency medicine physicians, neurologists, emergency medicine residents, nurses, physician assistants, nurse practitioners, and other health care professionals involved in the treatment of patients with AIS.
Educational material last updated...November 10, 2016.
CME Credit Expires...November 9, 2017.
Financial Support...Genentech, Inc.
The Best of Stroke Forum 2016 consists of two brief lectures:
• Eligibility for IV Thrombolysis: A Review of Inclusion and Exclusion Criteria
• Stroke Therapy: Examining New Evidence
After competing The Best of Stroke Forum 2016, you should be better able to:
• Apply evidence-based criteria to the selection of candidates for thrombolytic therapy in AIS.
• Evaluate FDA labeling, current data, and clinical practice guidelines on the use of tissue plasminogen activator in the extended 3-hour to 4.5-hour post-onset window.
• Assess recent studies and guidelines on endovascular procedures for AIS.
• Determine the criteria for the concomitant or preferential use of tissue plasminogen activator in patients with AIS who are being considered for endovascular procedures.
• Incorporate shared decision making with patients and their families to improve education and assist in reducing delays in treatment and complications.

Updates in Alzheimer's Disease: An Expert Interview Series
Posted by...Bernard Sklar, MD.
Free CME Credit Hours...0.5.
CME Credits Awarded by...Vindico Medical Education.
Cost for Credit...Free.
Instruction Type...Video Lectures.
Target Audience...Primary care providers, neurologists, gerontologists, radiologists, nuclear medicine physicians, and other health care professionals involved in the treatment of patients with Alzheimer's disease.
Educational material last updated...October 11th, 2016.
CME Credit Expires...October 10th, 2017.
Financial Support...Lilly.
Updates in Alzheimer's Disease consists of two brief lectures:
• Emerging Therapies for the Treatment of Alzheimer's Disease
• Alzheimer's Disease: Updates on Diagnostics and Early-stage Management
After competing Updates in Alzheimer's Disease, you should be better able to:
• Evaluate evidence-based strategies for the early diagnosis of Alzheimer's disease.
• Review the latest data of the pathophysiology and management strategies for pre-symptomatic and mild Alzheimer's disease.
• Evaluate the latest safety and efficacy data for new and emerging agents for the treatment of Alzheimer's disease.

A 360° Approach to Translating MS Data into Optimal Practice
Free Multiple Sclerosis CME
Posted by...Bernard Sklar, MD.
CME Credit Hours...3.0.
CME Credits Awarded by...Consortium of Multiple Sclerosis Centers.
Cost for Credit...Free.
Instruction Type...Webinar with Audio Commentary.
Target Audience... This educational initiative is intended to meet the needs of neurologists, nurses, nurse practitioners, physician assistants, rehabilitation professionals, case managers, mental health professionals, social workers and others involved in the management of patients with MS.
Educational material last updated...July 31, 2017.
CME Credit Expires...July 30, 2018.
Financial Support... Biogen and Sanofi Genzyme.
A 360° Approach to Translating MS Data into Optimal Practice focuses on practical topics, review clinical trial data with clarity and thoroughness, and incorporates cases to engage you on how this information can be used in clinical practice, for all disciplines involved in the care of patients with MS.
Upon completion of A 360° Approach to Translating MS Data into Optimal Practice, you should be better able to:
• Analyze data from clinical trials of disease modifying therapies to inform personalized treatment and monitoring of outcomes for patients with MS
• Access reliable and evidence-based resources in order to stay current with advances in the management of MS
• Integrate new and emerging information on the pathophysiology of MS, including modifiable risk factors, in the development of individualized treatment plans

Treatment Updates on Chronic Inflammatory Demyelinating Polyneuropathy Free Neurology CME
Live online July 27, 2017 and available on demand through July 27, 2018.
Posted by...Bernard Sklar, MD.
Free Neurology CME Credit hours..1.0.
CME Credits Awarded by....Postgraduate Institute for Medicine.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for US-based neurologists, immunologists, physician assistants, nurse practitioners, and nurses who manage, or have an interest in managing patients with immune-mediated neuropathies.
Educational material updated...July 27, 2017.
Expiration of CME credit...July 27, 2018.
Financial Support...Genentech.
Treatment Updates on Chronic Inflammatory Demyelinating Polyneuropathy emphasizes the use of IVIg in the treatment of Chronic Inflammatory Demyelinating Polyneuropathy. The presentation consists of a single lecture, Treatment Updates on Chronic Inflammatory Demyelinating Polyneuropathy, with discussion by Roy L. Freeman, MD, Richard J. Barohn, MD and Kenneth C. Gorson, MD. 
After viewing Treatment Updates on Chronic Inflammatory Demyelinating Polyneuropathy , you will be better able to :
• Conduct a thorough and timely evaluation and differential diagnosis of patients with chronic inflammatory demyelinating polyneuropathy.
• Devise appropriate treatment regimen for the effective management of chronic inflammatory polyneuropathy based on guidelines and clinical evidence. 

Neuropsychiatric Sequelae Virtual Curriculum Series: Agitation, Depression, and Pseudobulbar Affect Free Diabetes CME
Live online April 4, 2017 and available on demand through June 23, 2018.
Posted by...Bernard Sklar, MD.
Free Neuropsychiatry CME Credit hours..2.0.
CME Credits Awarded by....Albert Einstein College of Medicine.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for US-based neurologists, psychiatrists, geriatricians, primary care clinicians and health care providers involved in the care of patients with neuropsychiatric sequelae who may be suffering from agitation as a result of Alzheimer's disease (AD).
Educational material updated...April 4, 2017.
Expiration of CME credit...June 23, 2018.
Financial Support...Avanir Pharmaceuticals, Inc.
Neuropsychiatric Sequelae Virtual Curriculum Series: Agitation, Depression, and Pseudobulbar Affect consists of two sections: Mechanisms and Management of Agitation in Alzheimer's Disease and Challenges in Managing Treatment-Resistant Depression.
After viewing Neuropsychiatric Sequelae Virtual Curriculum Series, you will be better able to :
• Identify different and various forms of agitation among patients with Alzheimer's disease (AD).
• Review proposed mechanisms underlying agitation in AD and how pharmacologic agents may affect them
• Evaluate body of evidence of current and emerging pharmacologic agents for the management of agitation/aggression in patients with AD

Treatment strategies in Hunter Syndrome Free Genetics CME
Posted by...Bernard Sklar, MD.
Free Pulmonology and Genetics CME Credit Hours...1.0.
CME Credits Awarded by....ScientiaCME.
Cost..........Free.
Instruction Type....Slide-Video Lectures.
Target Audiences....Pediatricians, neurologists, endocrinologists, and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists; and any other healthcare professionals with an interest in or who may clinically encounter patients with Hunter syndrome.
Educational material last updated...June 29, 2017.
Expiration of CME credit...June 29, 2019.
Financial Support...Shire.
Hunter syndrome is an X-linked recessive genetic disease characterized by a deficiency of lysosomal enzymes responsible for the hydrolysis of glycosaminoglycans (GAGs), with males more likely to develop disease and females more likely to be carriers.
After reviewing Treatment strategies in Hunter Syndrome, you will be able to:
• Describe the importance of earlier treatment and diagnosis of Hunter syndrome in patients
• Determine the likelihood of Hunter syndrome using with established diagnosis methods, given a patient case
• Describe options available to treat Hunter syndrome and design a medical plan to treat a patient with Hunter syndrome
• Describe present barriers to care in the treatment of patients with Hunter syndrome

Lennox-Gastaut Syndrome: Improving Patient Outcomes Through Better Diagnosis and Management Free Neurology CME 
Live online October 7, 2016, and available on demand through October 13, 2017.
Posted by...Bernard Sklar, MD.
Free Neurology CME Credit hours...1.0.
CME Credits Awarded by....Albert Einstein College of Medicine and Montefiore Medical Center.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for US-based epileptologists, community neurologists (pediatric and adult), primary care physicians, pediatricians, medical directors from long-term care facilities, and other clinicians involved in the care of patients with Lennox-Gastaut Syndrome.
Educational material updated... October 7, 2016.
Expiration of CME credit... October 13, 2017.
Financial Support...Lundbeck.
Topics covered in Lennox-Gastaut Syndrome include: 
• Barriers to effective diagnosis and management of LGS (Lennox-Gastaut Syndrome) in pediatric and adult settings
• What is the "triad" and evolving seizure patterns of LGS as patients age
• Diagnostic approaches to differentiate LGS from other forms of epileptic encephalopathies
• Management strategies as patients age, seizure characteristics change, and behavioral or other issues arise
• Multidisciplinary approach to lifelong management of LGS and key elements for a smooth transition from pediatric to adult services
At the conclusion of Lennox-Gastaut Syndrome, you will be better able to:
• Identify characteristics associated with LGS from other forms of epilepsy, and evolving seizure profiles over the course of a patient's life
• Devise effective and tolerable pharmacotherapeutic treatment options for LGS as appropriate to pediatric and adult patients
• Evaluate the relative efficacy and safety of alternative therapies and nonpharmacologic strategies for the management of LGS
• Describe the key elements of a care plan that will ensure smooth transition from pediatric care to adult care in patients with LGS

Updates in Migraine Headaches: Best practices and Emerging Therapies in Treatment and Prevention 
Posted by...Bernard Sklar, MD. Free Neurology CME Free Pain Management CME
Free Neurology and Pain Management CME Credit hours...1.0.
CME Credits Awarded by....ScientiaCME.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...Healthcare professionals who are: primary care physicians, neurologists, headache specialists, nurse practitioners, physician assistants, nurses, OB-GYN specialists, pharmacists, and those who otherwise commonly care for or clinically encounter patients who may experience migraine headache.
Educational material updated...July 20, 2016.
Expiration of CME credit...July 20, 2018.
Financial Support...AMGEN and Promius.
After viewing Updates in Migraine Headaches, you will be able to:
• Describe the prevalence of migraine symptoms and the impact that these symptoms have on efficacy of anti-migraine therapy and functional status
• Describe the sometimes variable manifestations (e.g., incidence and clinical presentation) of migraine headaches, depending on age and sex
• Recall emerging therapies for the treatment and prevention of chronic migraine headache and anticipate their place in therapy
• Support team-based learning and communication between all clinicians involved with the care of patients suffering with migraines
• Given a series of patient cases, diagnosis and treat migraine headaches by employing current treatment guidelines, using evidence-based therapy algorithms, and providing individualized approaches to care

Alzheimer Disease (AD) and Its Complications: Best Practices, Emerging Therapies, and Barriers to Care Alzheimer's Disease CME 
Posted by...Bernard Sklar, MD.
Alzheimer's Disease CME Credit hours...1.0.
CME Credits Awarded by....ScientiaCME.
Cost...........Free.
Instruction Type...Streaming Video Lecture.
Target Audiences...Healthcare professionals specializing in: neurology, gerontology, internal medicine, palliative care, or those who otherwise commonly care for patients with AD or who frequently encounter them or their caregivers in practice.
Educational material updated...December 21, 2015.
Expiration of CME credit...December 21, 2017.
Financial Support...AVANIR.
Topics covered in Alzheimer Disease (AD) and Its Complications include:
Epidemiology of and risk factors for Alzheimer Disease (AD), Symptomatology and diagnosis of AD, Treatment in patients with AD, Complications and barriers to optimal care in patients with AD and many more.
After completing Alzheimer Disease (AD) and Its Complications, you will be able to:
• Describe what is presently known about the pathophysiology of AD and the challenges associated with diagnosis and treatment of AD.
• Evaluate a treatment plan for a specific patient based on degree of AD to optimize safety and efficacy, suggesting modifications for improvement.
• Identify the present treatment options currently available for management of AD and apply them to patient cases using evidence-based medicine.
• Describe emerging drug therapies in the treatment of AD.
• Describe barriers to care and suggest therapies for treating cognitive and behavioral complications secondary to AD. 
In order to get credit from ScientiaCME, you must first establish a username and password.

ScientiaCME Neuropsychiatry-Neurology Free Neurology CME ScientiaCME Neurology  
Posted by...Bernard Sklar, MD.
Neurology Credit hours...3.75.
CME Credits Awarded by....ScientiaCME.
Cost...........Free.
Instruction Type...Slide-Video Lectures.
Target Audience...NEUROLOGY.
CME Credit Expires...Two years after release.
Financial Support...Various commercial supporters. 

ScientiaCME Treatment strategies in Gaucher disease Free Gaucher Disease CME
CME Credit Hours...1.25.
CME Credits Awarded by....ScientiaCME.
Cost...........Free.
Instruction Type...Slide-Video Lectures.
Target Audience...Cardiology, genetic disorders, hematology, oncology, orthopedics, gastroenterology, neurology and pediatrics.
Educational material updated....February 12, 2017.
Expiration of CME credit...February 12, 2019.
Financial Support...Shire.
At the conclusion of By the end of Treatment strategies in Gaucher disease, you will be able to:
• Describe the importance of appropriate GD (Gaucher Disease) diagnosis and treatment (use • for bullets)
• Determine the likelihood of GD using with established diagnosis methods, given a patient case
• Describe present therapies for the treatment of GD and the literature supporting their use
• Design a medical plan to treat a patient with GD, taking into account presently available therapies





-->